StockData
Natures Sunshine Products Inc logo

Natures Sunshine Products Inc (NATR) stock

NATRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3058% below fair value
$10.33−0.23 (-2.18%)

Close on Nov 17, 2026Market cap $181.76MP/E 10.2Yield –

Natures Sunshine Products total assets

Total assets on the balance sheet at the end of each period.

Natures Sunshine Products's total assets was $259.82M at Jun 30, 2026. For fiscal 2025 it was $261.15M, up 8.4% from the year before. Over ten years it grew 2.7% a year on average. The highest annual figure on record is $261.15M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$261.15M+8.4%
FY2024Dec 31, 2024$240.86M-3.6%
FY2023Dec 31, 2023$249.77M+8.7%
FY2022Dec 31, 2022$229.78M-11.2%
FY2021Dec 31, 2021$258.87M+3.8%
FY2020Dec 31, 2020$249.50M+17.1%
FY2019Dec 31, 2019$213.07M+10.4%
FY2018Dec 31, 2018$193.02M-1.1%
FY2017Dec 31, 2017$195.20M-5.0%
FY2016Dec 31, 2016$205.57M+2.5%
FY2015Dec 31, 2015$200.52M+1.9%
FY2014Dec 31, 2014$196.80M-1.4%
FY2013Dec 31, 2013$199.61M+2.9%
FY2012Dec 31, 2012$193.92M+10.3%
FY2011Dec 31, 2011$175.81M+10.3%
FY2010Dec 31, 2010$159.42M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$259.82M+1.9%
Q1 FY2026Mar 31, 2026$261.46M+3.5%
Q4 FY2025Dec 31, 2025$261.15M+8.4%
Q3 FY2025Sep 30, 2025$264.81M+7.9%
Q2 FY2025Jun 30, 2025$254.88M+8.1%
Q1 FY2025Mar 31, 2025$252.70M+2.2%
Q4 FY2024Dec 31, 2024$240.86M-3.6%
Q3 FY2024Sep 30, 2024$245.33M+2.3%
Q2 FY2024Jun 30, 2024$235.83M-0.1%
Q1 FY2024Mar 31, 2024$247.27M+5.4%
Q4 FY2023Dec 31, 2023$249.77M+8.7%
Q3 FY2023Sep 30, 2023$239.91M+7.3%
Q2 FY2023Jun 30, 2023$236.15M+1.3%
Q1 FY2023Mar 31, 2023$234.58M-1.7%
Q4 FY2022Dec 31, 2022$229.78M-11.2%
Q3 FY2022Sep 30, 2022$223.51M-6.8%
Q2 FY2022Jun 30, 2022$233.06M-0.1%
Q1 FY2022Mar 31, 2022$238.66M-2.9%
Q4 FY2021Dec 31, 2021$258.87M+3.8%
Q3 FY2021Sep 30, 2021$239.75M+1.0%
Q2 FY2021Jun 30, 2021$233.19M+2.8%
Q1 FY2021Mar 31, 2021$245.83M+14.1%
Q4 FY2020Dec 31, 2020$249.50M+17.1%
Q3 FY2020Sep 30, 2020$237.42M+10.6%
Q2 FY2020Jun 30, 2020$226.93M+4.9%
Q1 FY2020Mar 31, 2020$215.44M+3.2%
Q4 FY2019Dec 31, 2019$213.07M+10.4%
Q3 FY2019Sep 30, 2019$214.75M+12.1%
Q2 FY2019Jun 30, 2019$216.25M+11.2%
Q1 FY2019Mar 31, 2019$208.78M+9.0%
Q4 FY2018Dec 31, 2018$193.02M-1.1%
Q3 FY2018Sep 30, 2018$191.53M-13.8%
Q2 FY2018Jun 30, 2018$194.46M-6.8%
Q1 FY2018Mar 31, 2018$191.55M-9.1%
Q4 FY2017Dec 31, 2017$195.20M-5.0%
Q3 FY2017Sep 30, 2017$222.21M+3.4%
Q2 FY2017Jun 30, 2017$208.56M–
Q1 FY2017Mar 31, 2017$210.74M–
Q4 FY2016Dec 31, 2016$205.57M–
Q3 FY2016Sep 30, 2016$214.90M–

More Natures Sunshine Products figures

See a number that looks wrong?